Pt Taisho Pharmaceutical Indonesia Tbk

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Indonesian Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about this company from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Legal Address
Wisma Tamara 10th Floor,Jl. Jenderal Sudirman Kav. 24
Jakarta; Jakarta; Map
Postal Code: 12920

Tel: +62-21-520-
Fax: +62-21-520-

Company Description
PT. Taisho Pharmeceutical Indonesia Tbk. (SQBI), formerly PT. Bristol-Myers Squibb Indonesia Tbk., operates in the development, registration, processing, production and selling of chemical, pharmaceutical and health care products. SQBI manufactures vitamins, analgesics, cardiovascular agents, steroids, antifungals, and antibiotics. In the production, company has tablet press machine, comil, bohle mill; water purification, boiler and generator set facilities. SQBI purchases its raw materials from PT. Mead Johnson, Bristol-Myers Squibb and Lawrence Laboratories. SQBI sells their products locally and exports to the Philippines, Malaysia, Hong Kong, Singapore, Ireland, Italy and Thailand. SQBI was listed on Indonesia Stock Exchange in 1983 under Development Board. The company was founded in 1970 and based in Jakarta, Indonesia.
NAICS Industry Classification
Basic Information
Key Executives
Ownership Details
Key Financial Highlights
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score

What this report allows you to do

EMIS company reports provide the data you need to make accurate assessments about businesses you are interested in.

Identify sales opportunities

  • Does the company match your target demographic?
  • Who are the key executives?

Conduct risk assessment

  • Is the company creditworthy?
  • Is it financially stable?

Carry out strategic research

  • Is the company a potential business partner/investment opportunity?
  • What is its financial performance?

You’re in good company

EMIS company reports are used extensively by the world’s biggest companies, financial institutions, professional service companies and universities to assess businesses in emerging markets.


company profiles

We have information on both public and private companies across 125 countries.



EMIS is the go-to information source on emerging market companies for the world’s most prestigious businesses.

Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Contact us to learn more about our business solutions.
Sign up to our newsletter

Make sure you’re not the last to know by getting the latest insights on emerging markets straight to your inbox.